1984
DOI: 10.1016/0277-5379(84)90067-1
|View full text |Cite
|
Sign up to set email alerts
|

Sodium-2-mercaptoethanesulfonate (MESNA) and Ifosfamide Nephrotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

1988
1988
2009
2009

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…This difference in sensitivity may be due to differences in biotransformation capacity [220]. Since 2-mercaptoethane sulphonate (MESNA) protects rats against nephrotoxicity and carcinogenicity induced by oxidative stress by increasing free thiol groups in kidney [221,222], the potential protective effect of MESNA on renal toxicity and carcinogenicity induced by OTA was examined in a long term rat study [223]. MESNA significantly decreased karyomegalies in kidney of all OTA-treated animals but had no beneficial effect on renal tumour incidence.…”
Section: Carcinogenicitymentioning
confidence: 99%
“…This difference in sensitivity may be due to differences in biotransformation capacity [220]. Since 2-mercaptoethane sulphonate (MESNA) protects rats against nephrotoxicity and carcinogenicity induced by oxidative stress by increasing free thiol groups in kidney [221,222], the potential protective effect of MESNA on renal toxicity and carcinogenicity induced by OTA was examined in a long term rat study [223]. MESNA significantly decreased karyomegalies in kidney of all OTA-treated animals but had no beneficial effect on renal tumour incidence.…”
Section: Carcinogenicitymentioning
confidence: 99%
“…However, even in pa tients on adequate mesna therapy and without cystitis, nephrotoxic effects are detectable. Several cases of severe tubular dysfunction have been reported, in some cases children developed Fanconi syndrome after IF therapy [10][11][12][13][14]. Nephrotoxicity with tubular dysfunc tion is not a typical side effect of CP.…”
Section: Introductionmentioning
confidence: 99%
“…A well-known side effect of IF is the development of hemorrhagic cystitis which is ascribed to the toxic metabolite acro lein [6,7]. Hemorrhagic cystitis can be pre vented by concomitant application of the uroprotective drug sodium-2-mercaptoethanesulfonate (Mesna) [8,9], Recent reports [10][11][12][13][14] show that even in patients on Mesna therapy and without hemorrhagic cystitis, there is a low but significant percentage of nephrotoxic side effects in children on IF ther apy, ranging from mild tubular dysfunction to severe tubular damage resulting in irrevers ible Fanconi syndrome. As there is little in formation about pathomechanisms and me tabolites involved in tubulotoxicity after IF, we decided to establish an experimental mod el of Fanconi syndrome induced by IF me tabolites.…”
mentioning
confidence: 99%